Saudi Arabia Antiviral Drugs Market Size & Outlook
Saudi Arabia antiviral drugs market, 2018-2030 (US$M)
Related Markets
Saudi Arabia antiviral drugs market highlights
- The Saudi Arabia antiviral drugs market generated a revenue of USD 508.8 million in 2022 and is expected to reach USD 329.8 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of -5.3% from 2023 to 2030.
- In terms of segment, hiv was the largest revenue generating application in 2022.
- HIV is the most lucrative application segment registering the fastest growth during the forecast period.
Antiviral drugs market data book summary
| Market revenue in 2022 | USD 508.8 million |
| Market revenue in 2030 | USD 329.8 million |
| Growth rate | -5.3% (CAGR from 2022 to 2030) |
| Largest segment | Hiv |
| Fastest growing segment | HIV |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | HIV, Hepatitis, Herpes, Influenza |
| Key market players worldwide | Roche Holding AG, GSK PLC ADR, AbbVie Inc, Merck & Co Inc, Johnson & Johnson, Bristol-Myers Squibb Co, Dr Reddy's Laboratories Ltd ADR, Aurobindo Pharma |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.7% of the global antiviral drugs market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia antiviral drugs market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 134.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antiviral Drugs Market Scope
Antiviral Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia antiviral drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antiviral drugs market will help companies and investors design strategic landscapes.
Hiv was the largest segment with a revenue share of 25.33% in 2022. Horizon Databook has segmented the Saudi Arabia antiviral drugs market based on hiv, hepatitis, herpes, influenza covering the revenue growth of each sub-segment from 2018 to 2030.
Despite having a low local output of branded drugs relative to generic products, Saudi Arabia has the largest pharmaceutical market in the Middle East and African region. Moreover, the country is experiencing an increased prevalence of viral diseases, specifically influenza.
According to the Saudi Ministry of Health, seasonal influenza causes a variety of complications, the most serious of which are bronchitis, pneumonia, blood poisoning, ear infection, and death. As a result of which, in October 2022, the Ministry of Health launched an awareness campaign to encourage seasonal influenza vaccination, focusing on groups most vulnerable to it, such as the elderly, people with chronic diseases or immunodeficiency, healthcare workers, and pregnant women.
Moreover, in Saudi Arabia, HSV-1 infection is common and almost certainly acquired before adulthood, whereas HSV-2 prevalence is extremely low, acquired throughout adulthood, and grows with age. Acyclovir is one of the most prescribed drugs in the country. The rising prevalence of viral diseases is further anticipated to drive the growth of the overall market in the country.
Reasons to subscribe to Saudi Arabia antiviral drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia antiviral drugs market databook
-
Our clientele includes a mix of antiviral drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia antiviral drugs market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia antiviral drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia antiviral drugs market size, by application, 2018-2030 (US$M)
Saudi Arabia Antiviral Drugs Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
